Literature DB >> 14719229

Biological and clinical markers of disease activity in ankylosing spondylitis.

María Carmen Muñoz-Villanueva, Elisa Muñoz-Gomariz, Alejandro Escudero-Contreras, Verónica Pèrez-Guijo, Eduardo Collantes-Estévez.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14719229

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  5 in total

1.  Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies.

Authors:  Vishu Vijayant; Manjit Sarma; Hrushikesh Aurangabadkar; Lata Bichile; Sandip Basu
Journal:  World J Radiol       Date:  2012-12-28

2.  Early spondyloarthropathy: scintigraphic, biological, and clinical findings in MRI-positive patients.

Authors:  Orhan Akdeniz; Gamze Alayli; Fevziye Canbaz Tosun; Bariş Diren; Kivanç Cengiz; Mustafa Bekir Selçuk; Tevfik Sünter; Ferhan Cantürk
Journal:  Clin Rheumatol       Date:  2007-09-15       Impact factor: 2.980

3.  Predictive factors of radiographic progression in ankylosing spondylitis.

Authors:  Hyungjin Kim; Jaejoon Lee; Joong Kyong Ahn; Jiwon Hwang; Eun-Jung Park; Hyemin Jeong; Hoon-Suk Cha; Eun-Mi Koh
Journal:  Korean J Intern Med       Date:  2015-04-29       Impact factor: 2.884

4.  Circulating interleukin-23 levels in ankylosing spondylitis and their correlation with disease activity : A meta-analysis.

Authors:  Y H Lee; G G Song
Journal:  Z Rheumatol       Date:  2021-09       Impact factor: 1.372

5.  Elevated serum interleukin-23 levels in ankylosing spondylitis patients and the relationship with disease activity.

Authors:  Mahir Ugur; Nurcan Kilic Baygutalp; Meltem Alkan Melikoglu; Fatih Baygutalp; Elif Umay Altas; Buminhan Seferoglu
Journal:  Nagoya J Med Sci       Date:  2015-11       Impact factor: 1.131

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.